Recent epidemiological studies have reported a positive association between exposure to ambient concentrations of particulate matter (PM) and the incidence of cardiopulmohary-related morbidity and mortality. The present study examined the effects of fugitive residual oil fly ash (ROFA) PM on cardiac arrhythmia induction in healthy and cardiopulmonary-compromised rodents. Male Sprague-Dawley rats were implanted with radiotelemetry transmitters capable of monitoring the electrocardiogram and were subjected to one of two treatment regimens. Rats in the first treatment regimen (n = 16) served as normal control animals whereas rats in the second treatment regimen (n = 16) were injected with monocrotaline (MCT, 60 mg/kg, ip) to induce pulmonary vascular inflammation and hypertension and served as a model of cardiopulmonary disease. Rats within each treatment regimen were equally divided into four dose groups (0.0, 0.25, 1.0, 2.5 mg ROFA), instilled intratracheally, and monitored for 96 h. In the animals in the first treatment regimen, ROFA instillation caused dose-related increases in the incidence and duration of serious arrhythmic events that appeared to be associated with impaired atrioventricular conduction and myocardial hypoxia. There were no lethalities in the normal animals following ROFA instillation. The frequency and severity of arrhythmias were greatly exacerbated in the MCT-treated animals in the second treatment regimen and were accompanied by one, three, and two deaths in the low-, medium-, and high-dose groups, respectively. The results of the present study demonstrate substantial cardiac effects in normal and compromised rats after exposure to ROFA PM and implicate both conductive and hypoxemic arrhythmogenic mechanisms in the observed cardiac-related lethalities. These results support previous epidemiological studies that suggest a link between preexisting cardiopulmonary disease and potentiation of adverse health effects following exposure to anthropogenic particulateS. O 1998 Sodety of Toifco4ogy.
Recent epidemiological studies (Burnett et al., 1995; Lyon et al., 1995; Pope et al., 1992; Schwartz, 1993 Schwartz, , 1994 Schwartz and Dockery, 1992; Schwartz and Morris, 1995) have reported a positive association between the concentration of ambient particulate matter (PM) and the incidence of cardiopulmonary morbidity and mortality, as measured by the frequency and outcome of cardiac-and respiratory-related emergency room visits and hospital admissions. Although somewhat difficult to quantify, the most serious effects were observed in patients with chronic heart disease, chronic obstructive pulmonary disease, or pneumonia, strongly suggesting that preexisting cardiopulmonary disease might be a substantial risk factor in PM toxicity. To date, there have been few studies conducted to assess these effects using animal models. Nearing et al. (1996) have examined the electrocardiograms (ECG) of normal dogs exposed to concentrated urban air and reported evidence of cardiotoxicity. Similar studies (that did not monitor ECG waveforms) with rats, carried out by the same group, observed significant lethality after PM exposure and proposed that the lethality may be due to direct effects on cardiac tissue leading to ventricular fibrillation (Godleski, 1995; Godleski et al., 1996) .
To further investigate the toxicity of PM exposure, our laboratory instilled fugitive residual oil fly ash (ROFA) particles intratracheally in healthy and cardiopulmonary-compromised rats previously implanted with radiotelemetry transmitters and examined a number of physiological, biochemical, and morphological parameters. This communication will focus on the induced changes in ECG rhythm and waveform features and the concomitant lethality observed after exposure to ROFA PM. Additional results will be reported in subsequent articles. 1 This paper has been reviewed by the National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. 2 To whom correspondence should be addressed.
METHODS
The general methodologies and procedures used in this study have been previously described (Watkinson et al., 1995) and will be briefly summarized with any applicable modifications.
Animals. Adult, male Sprague-Dawley rats (n = 32) were obtained (Charles River Breeding Laboratory; Raleigh, NC) at ~60 days of age and housed in pairs in polycarbonate cages (28 X 17 X 12 cm) on previously heat-treated pine shaving bedding in a temperature-(22-23°C), humidity-(50-60% RH), and light-controlled (12 h light:12 h dark), biologically clean room until studied. They were allowed access to tap water and laboratory feed ad libitum. Unless otherwise noted, these conditions were maintained throughout the experimental time period. Animals were studied at "• 77-90 days of age and ranged in weight from 315 to 415 g. Animals were examined daily and all appeared healthy at the beginning of the study; with the exception of the purposefully induced lesions noted below, there were no additional signs of infirmity or distress due to any of the experimental procedures or treatments.
Particles. The ROFA particles used in this study were derived from smokestack filters obtained from the Florida Power and Light Company. These particles have been characterized (Dreher et al.. 1997; Hatch et al., 1985) and shown to have an average diameter of 1.9 /im, and contain high levels of soluble vanadium, iron, and nickel. For a more complete description of the properties of these particles, see Hatch et al. (1985) and Dreher et al. (1997) .
Data acquisition and exposure systems. Radiotelemetry methodology was used in this study to permit the monitoring and acquisition of physiological data from unanesthetized, unrestrained animals. The radiotelemetry system (Data Sciences International, Inc.; St. Paul, MN) was capable of transmitting continuous electrocardiographic, temperature, and activity signals from multiple animals. All ECG waveforms were visually displayed on a high-resolution, integrated monitor (Model FS6605ETK; Mitsubishi) for the entire experimental time period and continuously recorded using a programmable, dualspeed, 16-channel chart recorder (Model MT95K2; Astro-Med, Inc.). The high-speed chart records (50 mm/s X 10 s) were used for subsequent arrhythmia analyses. These recordings were obtained at periodic intervals (~ 4 h) over the 2 days prior to ROFA instillation to provide preexposure control samples. Immediately after ROFA instillation, similar expanded rhythm strips were obtained at 5-min intervals for the first 2 h, at 10-min intervals for the next 4 h, and at 30-min intervals for the remainder of the 96-h experimental time period.
During the data acquisition period, animals were individually housed in polycarbonate cages in a specially designed climate-controlled exposure chamber (130 X 125 X 75 cm) that allowed telemetric monitoring and recording of ECG signals from 16 rats simultaneously. The ambient conditions in the exposure chamber were rigorously controlled and maintained within the ranges specified above, with food and water provided ad libitum.
Experimental preparation. Animals were weighed and then anesthetized with sodium pentobarbital (Nembutal; Abbott Laboratories; 50 mg/kg, ip). Using aseptic surgical procedures, each animal was implanted with a radiotelemetry transmitter (Model TA11CTA-F40; Data Sciences International, Inc.). The transmitter module was placed in the abdominal cavity and the electrode leads were tunneled subcutaneously across the ventral surface and terminated in positions which approximated the Lead II of the ECG. Body heat was maintained both during and immediately after surgery via external means. Animals were allowed ~ 10 days to recover from the surgery and to reestablish normal circadian patterns.
Experimental procedure. Animals were equally divided into two treatment regimens (n = 16/regimen) and this study was conducted in two phases according to regimen. At 10 days postsurgery, telemetric monitoring of the ECG was begun in the first treatment regimen animals and continued throughout the remainder of the study. Telemetric waveforms were monitored for 2 days to obtain baseline conditions. Animals were then removed from the chamber, briefly (< 1 min) anesthetized with halothane, intubated with a tracheal tube, and instilled with one of four doses of ROFA PM (0.0, 0.25, 1.0, or 2.5 mg) suspended in 0.3 ml normal saline. Animals were returned to the exposure chamber (< 20 min) and monitored for an additional 4 days. Animals in the second treatment regimen were treated identically to those of the first regimen with the following exception: at 10 days postsurgery, rats in the second treatment regimen were injected with monocrotaline (MCT; Aldrich Chemical Corp.; 60 mg/kg, ip) and allowed 12 days for the development of pulmonary inflammation and initiation of the pulmonary hypertensive response, as per Reindez et al. (1990) . After this incubation period, the secondregimen MCT-treated rats resumed the same protocol as the rats in the first treatment regimen.
Data analysis. All high-speed chart records of ECG waveforms were examined for rhythm disturbances and feature anomalies. Arrhythmias observed during the experimental time period were quantified by frequency and type, and their rate of occurrence was normalized with respect to the total electrocardiographic waveform sampling time per day, e.g., the numbers of arrhythmias identified on Days 2, 3, and 4, when fewer high-speed chart records were generated, were weighted with respect to the more frequently obtained data from Day 1. These arrhythmia data were examined qualitatively for uniformity and trends; more rigorous quantitative analyses of other telemetric data, including changes in electrocardiographic intervals, durations, and rates, were also carried out and have been reported separately .
RESULTS
Electrocardiographic data. Analysis of the ECG data from animals exposed to ROFA PM in the first treatment regimen (normal rats) demonstrated a substantial number of waveform anomalies and arrhythmic events. In contrast, there were only limited irregularities observed in the time-paired, saline-treated control animals. The incidence and duration of ROFA-induced arrhythmias were dose-related and these rhythm disturbances ranged from modest changes in R-R intervals, episodic premature atrial or ventricular contractions, and occasional skipped QRS complexes to more serious hypoxemia-related disturbances, multiple premature contractions or skipped QRS complexes, and advanced atrioventricular conduction blocks (Fig. 1) . Particularly noteworthy were the frequently observed second-degree atrioventricular conduction blocks in the ROFA-treated rats. While somewhat unusual, these arrhythmias appeared to be most similar to the Mobitz Type II arrhythmia subclassification in humans. They were characterized by having generally similar P-R intervals until a QRS complex was dropped; following the initial skipped QRS complex, there were often continual sequential P-waves spaced very far apart that were not followed by QRS complexes, and there was no regular relationship or predictability between the number of P-waves and the number of QRS complexes. Arrhythmias observed in the animals in the second treatment regimen (MCT-treated rats) were similar in nature to those of the first treatment regimen, although their incidence and severity were greatly exacerbated.
Due to the episodic monitoring constraints of the experimental protocol (e.g., arrhythmia analyses could only be conducted using the high-speed chart records and it was prohibitive to continuously record at high speed), it was not possible to detect and quantify all of the ECG abnormalities that occurred. Furthermore, because ECG waveforms were recorded at the high chart speed for as few as 10 s per 30-min interval, it is clear that the prevalence of rhythm disturbances was manyfold greater than that shown by analysis of the chart records. The arrhythmic events that were recorded were tabulated by frequency and type (Tables 1A, IB) and MCT-treated rats. Additional analyses conducted using data normalized with respect to total ECG sampling time per day showed that the incidence of ECG irregularities diminished over the 4-day experimental time period following ROFA instillation in the normal animals, whereas it was clearly sustained or potentiated in the MCT-treated animals.
Lethality. There were no lethalities among the animals in the first treatment regimen; however, 7 of the 16 MCT-treated rats in the second treatment regimen died within the experimental time period (Tables 1A, IB) . One animal died 11 days after injection of MCT (prior to instillation of the ROFA PM) and postmortem examination of the lungs of this rat showed severe multifocal hemorrhage. Six of the 12 MCT-treated rats that were also exposed to ROFA PM (1, 3, and 2 rats in the low-, medium-, and high-dose groups, respectively) died, apparently of cardiac-related causes. These mortality rates were consistent with those of other studies from our laboratory involving MCT-and ROFA-treated rats (Kodavanti et al., 1997) . The time of the deaths in the present study ranged from 4 to 71 h postinstillation. In half of these animals, the monitored ECG waveforms exhibited features characteristic of myocardial hypoxia (e.g., decreased heart rate, depressed S-T segment area, high peaked T-waves) that became progressively more severe in the hours preceding death, whereas the ECG waveforms of the other animals that died appeared to terminate abruptly with little or no prior indication of functional problems. Illustrative examples of these two scenarios are shown in Figs. 2 and 3, respectively.
DISCUSSION
The results of the present study demonstrated substantial dose-related cardiac effects in healthy rats exposed to ROFA PM. These adverse effects were characterized by increases in the frequency and severity of ECG anomalies and dysrhythmias and were accompanied by significant decreases in important indices of systemic physiological function, such as heart rate and core body temperature, and increases in biomarkers of lung injury (Campen et al., 1996) . The ROFA-treated animals commonly exhibited progressively advanced second-degree atrioventricular blocks, events that in humans are often a precursor of more serious ventricular conduction problems. Furthermore, these effects were greatly potentiated in rats whose cardiopulmonary function had been compromised by MCT-induced pulmonary inflammation and hypertension, with a resultant lethality rate of 50% in these animals. Although the extrapolation of these data to epidemiological studies must be tempered by the nature of the particle employed (highly toxic ROFA) and the route of delivery (intratracheal instillation), these studies appear to support a role for cardiac involvement in the excess morbidity and mortality associated with ambient particle exposure (Burnett et al., 1995; Lyon et al, 1995; Pope et al., 1992; Schwartz, 1993 Schwartz, , 1994 Schwartz and Dockery, 1992; Schwartz and Morris, 1995) .
Concurrent ECG waveforms obtained from the animals in the present study suggested two possible scenarios for the observed lethalities. In the first scenario, there appeared to be a relatively slow failure of the myocardium that may have been due to hypoxemic myocardial perfusion consequent to inflammatory-induced pulmonary edema. Exposure to ROFA PM is known to produce an acute pulmonary inflam- Note. Table denoting incidence and type of observed electrocardiographic waveform anomalies in unanesthetized, adult Sprague-Dawley rats after intratracheal instillation of residual oil fly ash (ROFA) particles. Studies were conducted that compared the effects of four doses of particles in (A) healthy rats with those of (B) cardiopulmonary-compromised rats that had been preexposed to monocrotaline (60 mg/kg, ip) to induce pulmonary inflammation and pulmonary hypertension. The rate of occurrence of arrhythmic events was normalized with respect to the total electrocardiographic waveform sampling time per day and these results are summarized below each group. Types of arrhythmias are abbreviated as follows: R-R interval change (r), bundle branch block (bb), premature atrial contraction (a), premature ventricular contraction (v), skipped complex (No. of complexes skipped). Arrhythmia designations separated by a colon indicate sequential anomalies and an arrhythmia designation and a number separated with a x sign indicate multiple occurrences of similar dysrhythmias. ROFA instillations were conducted on Day 1 between 0900 and 1000 h for the normal rats and between 1400 and 1600 h for the MCT-treated rats, and subsequent experimental time periods were adjusted accordingly. Tune and day of lethalities are shown. matory response within the first few hours that peaks at 24-30 h and wanes slowly over the next several days (Kodavanti et al., 1996) . The inflammatory response is associated with significant pulmonary edema and alveolar membrane injury which, in turn, may compromise oxygen transport across respiratory surfaces and lead to hypoxemia. Preliminary studies from our laboratory (Gardner, unpublished observations) indicate that pretreatment with MCT may significantly increase ROFA-induced diffusion barriers. The ECG waveforms of three of the six rats that died Table 1B ) after intratracheal instillation of ROFA particles (1.0 mg). Individual waveform strips represent approximately 8 s sampling time and were obtained at slO-min intervals; actual time of sampling is shown on each record. Note the progressive development of hypoxia-like changes in electrocardiographic waveform features (e.g., bradycardia, depression of ST segment area, high peaked T-waves) and gradual cardiac failure culminating in asystole.
following pretreatment with MCT and subsequent exposure to ROFA PM demonstrated evidence of progressive hypoxic failure of the myocardium, including significant bradycardia, depressed S-T segment area, and high peaked T-waves, beginning several hours prior to death (Fig. 2) . These hypoxic indices became more frequent and pronounced over time, eventually culminating in asystole.
In contrast, the second scenario proposed to explain observed lethalities appeared to involve a rapid failure of the heart due to a fatal conduction-related arrhythmia. Thus, the ECG waveforms of the other animals that died showed little or no indication of myocardial hypoxia and these rats appeared to die abruptly. The waveforms of these rats exhibited prior signs of conduction-related deficiencies and increased myocardial irritability (Fig. 3) . The former were characterized primarily by different degrees of atriovcntricular and bundle-branch block, whereas the latter appeared as increased perturbations and "noise" in the ECG waveforms. Generally, the heart rates in these animals were slowed but steady in the monitored waveform strips recorded just prior (< 10 min) to the strips exhibiting cardiac standstill. It is possible that the combination of transient complete heart block and increased irritability permitted the initiation and propagation of an ectopically stimulated depolarization which "captured" the heartbeat, producing a fatal arrhythmia. Although the mechanism(s) underlying the above arrhythmogenesis is unknown, it has been proposed that transition metals (e.g., iron, vanadium, nickel), which are important constituents of ROFA PM, may play a role by acting directly on the heart muscle or via a second messenger following interaction and release of mediators (e.g., cytokines) from the lung (Dreher et al., 1997; Godleski, 1995) . These arrhythmic events may also be partially mediated via parasympathetic reflexes. Preliminary studies were conducted in our laboratory (unpublished observations) in which acetylcholine (ACh, 0.05-0.25 mg) was rapidly infused intravenously in both ROFA-and saline-exposed rats to examine its arrhymogenic effects. These experiments demonstrated arrhythmias qualitatively similar to those observed spontaneously in rats from the two treatment regimens described above. Thus, arrhythmias were induced following ACh exposure which showed multiple premature contractions, advanced atrioventricular conduction blocks, and complete heart block with spontaneous recovery. It is particularly noteworthy that the latter abnormality is relatively rare in the rat and appeared to closely mimic those seen with exposure to ROFA PM.
Exposure to ROFA in both normal and MCT-treated animals was associated with a dose-related increase in the incidence and duration of arrhythmia induction. However, there was no obvious dose-dependent pattern with respect to the observed lethalities. There were deaths in all ROFA dose groups in the MCT-treated animals and, although more animals died in the medium-dose group than in the highdose group, the rats in the latter group succumbed earlier. While the inability to ascribe correlation is probably due to a combination of factors, it is apparent that rats pretreated with MCT were sensitive to all ROFA doses used in this study. It is well established that exposure to MCT in rodents according to the protocol employed above induces lesions in the pulmonary vasculature endothelium stimulating an inflammatory response (Meyrick et al., 1980; Reindez et al 1990; Wilson et al., 1992) . Subsequent repair processes involving medial smooth muscle thickening and accelerated deposition of collagen lead to increased vascular resistance, higher pulmonary arterial pressure, and right ventricular hypertrophy. In a recent study employing the present exposure protocol and using radiotelemetry methodology to monitor the development of the pulmonary hypertensive response in the unrestrained rat, Hess et al. (1996) reported an average increase of 58% in pulmonary arterial pressure in conjunction with a 37% increase in the ratio of the weights of the right ventricle/left ventricle plus septum (RV/LV + S). Postmortem examination of the surviving rats in the present study showed a similar degree of right ventricular hypertrophy, with RV/LV + S weight ratios of 0.35 i 0.06 for MCT-treated animals versus 0.26 ± 0.06 for normal animals (35% increase; p < 0.001; Campen et al., 1997) ; it is likely that the animals that died prematurely had comparable or even greater progression of disease. There is a high degree of variability in the response to MCT, however, and because it was not possible to obtain concurrent functional measures of the degree of pulmonary injury and hypertension in the MCT-treated animals in the present study, it could not be determined if the initial severity of the cardiopulmonary disease was uniform across groups. Thus, some of the animals in the low-or medium-dose group may have been affected to the same or an even greater extent than some of the animals in the high-dose group, making it impractical to correlate the subsequent ROFA exposure with the observed lethality. Nevertheless, these data demonstrate a clear association between MCT-induced lung disease and cardiovascular toxicity following exposure to ROFA PM.
In summary, the results of the present study demonstrate significant cardiac effects in healthy rats after intratracheal exposure to ROFA PM, with these effects greatly potentiated in cardiopulmonary-compromised animals. To our knowledge, the observed anomalies in the ECG waveforms provide the first experimental evidence linking exposure to fly ash particles with cardiac arrhythmogenesis and lethality. The deaths observed in this study are consistent with mechanisms of either abrupt conduction-related or progressive hypoxemia-related cardiac failure. Although further research remains to be done, the results of the present study using a model fugitive PM appear to support the reported epidemiological association between increased cardiac-related morbidity and mortality and increased PM exposure.
